RU2009128067A - Варианты липаз для их применения в фармацевтике - Google Patents
Варианты липаз для их применения в фармацевтике Download PDFInfo
- Publication number
- RU2009128067A RU2009128067A RU2009128067/10A RU2009128067A RU2009128067A RU 2009128067 A RU2009128067 A RU 2009128067A RU 2009128067/10 A RU2009128067/10 A RU 2009128067/10A RU 2009128067 A RU2009128067 A RU 2009128067A RU 2009128067 A RU2009128067 A RU 2009128067A
- Authority
- RU
- Russia
- Prior art keywords
- lipase
- seq
- sequence
- amylase
- protease
- Prior art date
Links
- 239000004367 Lipase Substances 0.000 title claims abstract 76
- 102000004882 Lipase Human genes 0.000 title claims abstract 76
- 108090001060 Lipase Proteins 0.000 title claims abstract 76
- 235000019421 lipase Nutrition 0.000 title claims abstract 76
- 238000006467 substitution reaction Methods 0.000 claims abstract 20
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims abstract 19
- 235000019626 lipase activity Nutrition 0.000 claims abstract 13
- 238000000034 method Methods 0.000 claims abstract 12
- 102000057297 Pepsin A Human genes 0.000 claims abstract 10
- 108090000284 Pepsin A Proteins 0.000 claims abstract 10
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract 10
- 229940111202 pepsin Drugs 0.000 claims abstract 10
- 229910052698 phosphorus Inorganic materials 0.000 claims abstract 10
- 239000003814 drug Substances 0.000 claims abstract 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims abstract 9
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 8
- 238000007792 addition Methods 0.000 claims abstract 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 7
- 238000003776 cleavage reaction Methods 0.000 claims abstract 7
- 230000007017 scission Effects 0.000 claims abstract 7
- 102220479102 CD59 glycoprotein_N33Q_mutation Human genes 0.000 claims abstract 6
- 210000004051 gastric juice Anatomy 0.000 claims abstract 6
- 238000000338 in vitro Methods 0.000 claims abstract 6
- 238000002156 mixing Methods 0.000 claims abstract 5
- 102220204637 rs137852883 Human genes 0.000 claims abstract 5
- 102220033643 rs8069375 Human genes 0.000 claims abstract 5
- 102220536901 PRKC apoptosis WT1 regulator protein_L69I_mutation Human genes 0.000 claims abstract 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims abstract 3
- 239000000872 buffer Substances 0.000 claims abstract 3
- 102220360655 c.170A>G Human genes 0.000 claims abstract 3
- 238000011534 incubation Methods 0.000 claims abstract 3
- 102200158812 rs104894225 Human genes 0.000 claims abstract 3
- 102220008213 rs116840785 Human genes 0.000 claims abstract 3
- 102220082775 rs144148008 Human genes 0.000 claims abstract 3
- 102220057725 rs374836770 Human genes 0.000 claims abstract 3
- 102220045389 rs587782063 Human genes 0.000 claims abstract 3
- 102220330013 rs78488639 Human genes 0.000 claims abstract 3
- 102220020884 rs80356880 Human genes 0.000 claims abstract 3
- 102200114143 rs9282858 Human genes 0.000 claims abstract 3
- 239000001632 sodium acetate Substances 0.000 claims abstract 3
- 235000017281 sodium acetate Nutrition 0.000 claims abstract 3
- 102220515651 Insulin-like growth factor I_R84E_mutation Human genes 0.000 claims abstract 2
- 102220536108 Serine/threonine-protein kinase OSR1_K46M_mutation Human genes 0.000 claims abstract 2
- 102220600976 Syndecan-4_N26A_mutation Human genes 0.000 claims abstract 2
- 101150025207 VPK2 gene Proteins 0.000 claims abstract 2
- 101100049497 Variola virus (isolate Human/India/Ind3/1967) C14L gene Proteins 0.000 claims abstract 2
- 102200080817 rs104894869 Human genes 0.000 claims abstract 2
- 102220059022 rs786201869 Human genes 0.000 claims abstract 2
- 102220028139 rs80357084 Human genes 0.000 claims abstract 2
- 230000028327 secretion Effects 0.000 claims abstract 2
- 239000004382 Amylase Substances 0.000 claims 20
- 102000013142 Amylases Human genes 0.000 claims 20
- 108010065511 Amylases Proteins 0.000 claims 20
- 102000035195 Peptidases Human genes 0.000 claims 20
- 108091005804 Peptidases Proteins 0.000 claims 20
- 239000004365 Protease Substances 0.000 claims 20
- 235000019418 amylase Nutrition 0.000 claims 20
- 150000001413 amino acids Chemical class 0.000 claims 17
- 239000000203 mixture Substances 0.000 claims 7
- 239000003833 bile salt Substances 0.000 claims 6
- 229940093761 bile salts Drugs 0.000 claims 6
- 229920004890 Triton X-100 Polymers 0.000 claims 5
- 230000000694 effects Effects 0.000 claims 4
- 201000003883 Cystic fibrosis Diseases 0.000 claims 3
- 206010033645 Pancreatitis Diseases 0.000 claims 3
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 3
- 230000001079 digestive effect Effects 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 201000007089 exocrine pancreatic insufficiency Diseases 0.000 claims 3
- 235000021588 free fatty acids Nutrition 0.000 claims 3
- 239000000758 substrate Substances 0.000 claims 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 3
- 102220584273 Cellular tumor antigen p53_E56K_mutation Human genes 0.000 claims 2
- 102220564804 Killer cell immunoglobulin-like receptor 2DL2_N73D_mutation Human genes 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 239000007983 Tris buffer Substances 0.000 claims 2
- 239000003613 bile acid Substances 0.000 claims 2
- 102220412429 c.297A>C Human genes 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 102220276634 rs1553131563 Human genes 0.000 claims 2
- 102220277043 rs1553408229 Human genes 0.000 claims 2
- 102220104423 rs63749907 Human genes 0.000 claims 2
- 102220104592 rs879254078 Human genes 0.000 claims 2
- 102220105300 rs879254420 Human genes 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims 2
- 102220598657 5-hydroxytryptamine receptor 1E_D27R_mutation Human genes 0.000 claims 1
- 102220473558 ADP-ribosylation factor-like protein 2-binding protein_E56A_mutation Human genes 0.000 claims 1
- 102220524143 Cadherin-24_N26I_mutation Human genes 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- 102220568523 Clustered mitochondria protein homolog_E99S_mutation Human genes 0.000 claims 1
- 102220644676 Galectin-related protein_D96L_mutation Human genes 0.000 claims 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 claims 1
- 102220517768 Methyl-CpG-binding domain protein 3-like 2B_D27Y_mutation Human genes 0.000 claims 1
- 102220500768 Protein N-lysine methyltransferase METTL21D_D96V_mutation Human genes 0.000 claims 1
- 102220616017 Sterile alpha motif domain-containing protein 5_D96Y_mutation Human genes 0.000 claims 1
- 102220593678 Stromal interaction molecule 1_E87Q_mutation Human genes 0.000 claims 1
- 102220496421 Zinc finger CCHC domain-containing protein 24_E43V_mutation Human genes 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 231100000673 dose–response relationship Toxicity 0.000 claims 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 claims 1
- 229940049964 oleate Drugs 0.000 claims 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 102200161847 rs104894126 Human genes 0.000 claims 1
- 102200121669 rs104894915 Human genes 0.000 claims 1
- 102200006121 rs1060501260 Human genes 0.000 claims 1
- 102200014825 rs113203706 Human genes 0.000 claims 1
- 102200128615 rs121908750 Human genes 0.000 claims 1
- 102220312400 rs1555802310 Human genes 0.000 claims 1
- 102200068777 rs1805005 Human genes 0.000 claims 1
- 102200097285 rs199473487 Human genes 0.000 claims 1
- 102220271537 rs200383861 Human genes 0.000 claims 1
- 102220041065 rs200979664 Human genes 0.000 claims 1
- 102200108133 rs201753350 Human genes 0.000 claims 1
- 102220097791 rs201753350 Human genes 0.000 claims 1
- 102200110982 rs28931568 Human genes 0.000 claims 1
- 102200028671 rs3765620 Human genes 0.000 claims 1
- 102200027496 rs63751429 Human genes 0.000 claims 1
- 102200101939 rs72554338 Human genes 0.000 claims 1
- 102220056648 rs730881059 Human genes 0.000 claims 1
- 102220052839 rs73113102 Human genes 0.000 claims 1
- 102220084740 rs767734253 Human genes 0.000 claims 1
- 102200116704 rs77587352 Human genes 0.000 claims 1
- 102200058234 rs80338731 Human genes 0.000 claims 1
- 102220087418 rs864622444 Human genes 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 102220468054 Brother of CDO_N73Q_mutation Human genes 0.000 abstract 1
- 102220623143 Protein DGCR6_E87A_mutation Human genes 0.000 abstract 1
- 102220358508 c.297A>T Human genes 0.000 abstract 1
- 102200163576 rs28929478 Human genes 0.000 abstract 1
- 102220020411 rs397508256 Human genes 0.000 abstract 1
- 102220244268 rs550027484 Human genes 0.000 abstract 1
- 102220077759 rs797045050 Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Detergent Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87119606P | 2006-12-21 | 2006-12-21 | |
| US60/871,196 | 2006-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2009128067A true RU2009128067A (ru) | 2011-01-27 |
Family
ID=38043020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2009128067/10A RU2009128067A (ru) | 2006-12-21 | 2007-12-12 | Варианты липаз для их применения в фармацевтике |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US8273348B2 (enExample) |
| EP (6) | EP2455460A3 (enExample) |
| JP (1) | JP5406040B2 (enExample) |
| KR (1) | KR20090101930A (enExample) |
| CN (2) | CN101743308B (enExample) |
| AR (1) | AR064494A1 (enExample) |
| AU (1) | AU2007337150A1 (enExample) |
| BR (1) | BRPI0721103A2 (enExample) |
| CA (3) | CA3081308C (enExample) |
| IL (1) | IL198893A0 (enExample) |
| MX (1) | MX2009006597A (enExample) |
| NO (1) | NO20092729L (enExample) |
| RU (1) | RU2009128067A (enExample) |
| TW (1) | TW200829698A (enExample) |
| WO (1) | WO2008079685A2 (enExample) |
| ZA (1) | ZA200903598B (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110462037A (zh) * | 2017-01-30 | 2019-11-15 | 学校法人日本医科大学 | 腺相关病毒(aav)衣壳蛋白的突变体 |
| RU2712877C2 (ru) * | 2013-05-14 | 2020-01-31 | Новозимс А/С | Моющие композиции |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602005009677D1 (de) | 2004-03-22 | 2008-10-23 | Solvay Pharm Gmbh | Orale pharmazeutische zusammensetzungen von produkten mit lipase, insbesondere von pankreatin, mit tensiden |
| MX2008000850A (es) | 2005-07-29 | 2008-03-18 | Solvay Pharm Gmbh | Procedimientos para la fabricacion de polvo de pancreatina esterilizada. |
| US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
| US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
| US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
| EP2455460A3 (en) | 2006-12-21 | 2012-12-26 | Novozymes A/S | Lipase variants for pharmaceutical use |
| CA2716692A1 (en) | 2008-02-29 | 2009-09-03 | Dsm Ip Assets B.V. | Lipases with high specificity towards short chain fatty acids and uses thereof |
| BRPI0909707A2 (pt) * | 2008-02-29 | 2015-08-25 | Procter & Gamble | Composição detergente que compreende lipase. |
| CN101990573B (zh) * | 2008-02-29 | 2014-01-22 | 诺维信公司 | 具有改进的稳定性的脂肪分解酶变体及编码该变体的多核苷酸 |
| WO2011072117A1 (en) | 2009-12-09 | 2011-06-16 | The Procter & Gamble Company | Fabric and home care products |
| US20140147895A1 (en) | 2011-07-22 | 2014-05-29 | Novozymes A/S | Processes for Pretreating Cellulosic Material and Improving Hydrolysis Thereof |
| US8268305B1 (en) | 2011-09-23 | 2012-09-18 | Bio-Cat, Inc. | Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase |
| ES2887576T3 (es) * | 2011-12-29 | 2021-12-23 | Novozymes As | Composiciones detergentes con variantes de lipasa |
| WO2013113622A1 (en) * | 2012-02-03 | 2013-08-08 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
| CN104204198B (zh) * | 2012-04-02 | 2018-09-25 | 诺维信公司 | 脂肪酶变体以及编码其的多核苷酸 |
| CA2887898A1 (en) * | 2012-10-12 | 2014-04-17 | Danisco Us Inc. | Compositions and methods comprising a lipolytic enzyme variant |
| MX384253B (es) * | 2013-07-19 | 2025-03-14 | Danisco Us Inc | Composiciones y metodos que comprenden una variante de enzima lipolitica |
| US10287562B2 (en) * | 2014-11-20 | 2019-05-14 | Novoszymes A/S | Alicyclobacillus variants and polynucleotides encoding same |
| EP3227442B1 (en) * | 2014-12-05 | 2022-02-16 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
| MX382218B (es) * | 2014-12-09 | 2025-03-13 | Novozymes As | Variantes de lipasa y polinucleotidos que las codifican. |
| EP3280818A2 (en) | 2015-04-07 | 2018-02-14 | Novozymes A/S | Methods for selecting enzymes having lipase activity |
| CA3175255A1 (en) * | 2015-07-01 | 2017-01-05 | Novozymes A/S | Methods of reducing odor |
| EP3317389B1 (en) * | 2015-07-03 | 2019-04-10 | Novozymes A/S | Detergent compositions with improved stability in the presence of sulfites |
| WO2018015295A1 (en) | 2016-07-18 | 2018-01-25 | Novozymes A/S | Lipase variants, polynucleotides encoding same and the use thereof |
| BR112020006224A2 (pt) | 2017-09-27 | 2020-10-13 | Novozymes A/S | variantes de lipase e composições de microcápsulas compreendendo tais variantes de lipase |
| CN111108195A (zh) * | 2017-09-27 | 2020-05-05 | 宝洁公司 | 包含脂肪酶的洗涤剂组合物 |
| US20210071157A1 (en) * | 2018-02-08 | 2021-03-11 | Novozymes A/S | Lipase Variants and Compositions Thereof |
| EP3837276A4 (en) * | 2018-08-16 | 2022-05-18 | Isolere Bio, Inc. | Genetically encoded polypeptide for affinity capture and purification of biologics |
| CN111334369B (zh) * | 2020-03-11 | 2022-10-21 | 陕西科技大学 | 一种酶法制备卵磷脂型pufa的方法 |
| WO2021260148A1 (en) * | 2020-06-24 | 2021-12-30 | Cilian Ag | New lipase enzyme |
| US20240035005A1 (en) * | 2020-10-29 | 2024-02-01 | Novozymes A/S | Lipase variants and compositions comprising such lipase variants |
| CN113846074B (zh) * | 2021-10-20 | 2022-10-21 | 南京林业大学 | 一种疏棉状嗜热丝孢菌脂肪酶突变体g91c及其应用 |
| AU2023272468A1 (en) | 2022-05-14 | 2024-11-14 | Novonesis Plant Biosolutions A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
| CN119522274A (zh) * | 2022-06-24 | 2025-02-25 | 诺维信公司 | 脂肪酶变体和包含这样的脂肪酶变体的组合物 |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK173590D0 (da) * | 1990-06-06 | 1990-07-19 | Novo Nordisk As | Rekombinante terapeutiske lipaser |
| US5869438A (en) | 1990-09-13 | 1999-02-09 | Novo Nordisk A/S | Lipase variants |
| BR9106839A (pt) | 1990-09-13 | 1993-07-20 | Novo Nordisk As | Variante de lipase,construcao de dna,vetor de expressao de recombinante,celula,planta,processo para produzir uma variante de lipase,aditivo e composicao de detergente |
| DK46693D0 (enExample) | 1993-04-23 | 1993-04-23 | Novo Nordisk As | |
| WO1992010755A1 (en) | 1990-12-05 | 1992-06-25 | Novo Nordisk A/S | Proteins with changed epitopes and methods for the production thereof |
| EP0585285B1 (en) | 1991-05-01 | 1998-08-12 | Novo Nordisk A/S | Stabilized enzymes |
| DK39693D0 (da) | 1993-04-02 | 1993-04-02 | Novo Nordisk As | Enzym |
| EP0722491A1 (en) | 1993-10-04 | 1996-07-24 | Novo Nordisk A/S | An enzyme preparation comprising a modified enzyme |
| WO1995022615A1 (en) | 1994-02-22 | 1995-08-24 | Novo Nordisk A/S | A method of preparing a variant of a lipolytic enzyme |
| JPH10509324A (ja) | 1994-11-24 | 1998-09-14 | ノボ ノルディスク アクティーゼルスカブ | 抑制されたアレルゲン性を有するポリペプチドの製造のための方法 |
| AU697440B2 (en) | 1994-12-07 | 1998-10-08 | Novozymes A/S | Polypeptide with reduced allergenicity |
| AU710547B2 (en) | 1995-01-26 | 1999-09-23 | Novozymes A/S | Animal feed additives comprising xylanase |
| DE69633825T2 (de) | 1995-07-14 | 2005-11-10 | Novozymes A/S | Modifiziertes enzym mit lipolytischer aktivität |
| US6495357B1 (en) * | 1995-07-14 | 2002-12-17 | Novozyme A/S | Lipolytic enzymes |
| EP0851913B1 (en) | 1995-08-11 | 2004-05-19 | Novozymes A/S | Novel lipolytic enzymes |
| JP2002510963A (ja) | 1997-01-10 | 2002-04-09 | ノボザイムス アクティーゼルスカブ | スキンケア用酵素修飾体 |
| EP1017794A1 (en) | 1997-02-06 | 2000-07-12 | Novo Nordisk A/S | Polypeptide-polymer conjugates having added and/or removed attachment groups |
| ES2296336T3 (es) | 1997-06-25 | 2008-04-16 | Novozymes A/S | Polipeptido modificado. |
| ATE328070T1 (de) * | 1998-02-17 | 2006-06-15 | Novozymes As | Lipasevariante |
| AU3247699A (en) | 1998-02-17 | 1999-09-06 | Novo Nordisk A/S | Lipase variant |
| WO2000022103A1 (en) | 1998-10-13 | 2000-04-20 | Novozymes A/S | A modified polypeptide with reduced immune response |
| ATE390441T1 (de) | 1998-10-30 | 2008-04-15 | Novozymes As | Niedrigallergene proteinvarianten |
| ATE365210T1 (de) | 1998-10-30 | 2007-07-15 | Novozymes As | Glykosylierte proteine mit reduzierter allergenität |
| DK1131416T3 (da) | 1998-11-27 | 2009-10-26 | Novozymes As | Lipolytiske enzymvarianter |
| US7312062B2 (en) | 1998-11-27 | 2007-12-25 | Novozymes A/S | Lipolytic enzyme variants |
| DK1162995T3 (da) | 1999-03-17 | 2003-06-23 | Solvay Pharm Gmbh | Enzymer til behandling af diabetes mellitus type I |
| AU3420100A (en) * | 1999-03-31 | 2000-10-23 | Novozymes A/S | Lipase variant |
| CN100455663C (zh) * | 1999-03-31 | 2009-01-28 | 诺维信公司 | 脂肪酶变体 |
| AU777210C (en) | 2000-02-08 | 2005-08-04 | Dsm Ip Assets B.V. | Use of acid-stable subtilisin proteases in animal feed |
| AU2001254620A1 (en) | 2000-04-28 | 2001-11-12 | Novozymes A/S | Lipolytic enzyme variant |
| ES2323947T3 (es) | 2001-01-10 | 2009-07-28 | Novozymes A/S | Variante de enzima lipolitica. |
| AR032392A1 (es) | 2001-01-19 | 2003-11-05 | Solvay Pharm Gmbh | Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado. |
| CN1491278A (zh) | 2001-02-07 | 2004-04-21 | ŵά�Ź�˾ | 脂酶变体 |
| WO2003060112A1 (en) | 2002-01-16 | 2003-07-24 | Novozymes A/S | Lipolytic enzyme variants and method for their production |
| CA2514834A1 (en) | 2003-02-06 | 2004-08-19 | Novozymes A/S | Human heavy chain antibody expression in filamentous fungi |
| WO2004099400A2 (en) * | 2003-05-09 | 2004-11-18 | Novozymes A/S | Variant lipolytic ensymes |
| US20060251763A1 (en) | 2003-06-19 | 2006-11-09 | Patkar Shamkant A | Phospholipase variants |
| WO2004111224A1 (en) | 2003-06-19 | 2004-12-23 | Novozymes A/S | Improved proteases and methods for producing them |
| AR047440A1 (es) | 2004-01-21 | 2006-01-18 | Novozymes As | Produccion de un anticuerpo monoclonal en un hongo heterocarion o una celula huesped fungal |
| DE602005009677D1 (de) | 2004-03-22 | 2008-10-23 | Solvay Pharm Gmbh | Orale pharmazeutische zusammensetzungen von produkten mit lipase, insbesondere von pankreatin, mit tensiden |
| HUE031245T2 (en) | 2004-10-14 | 2017-06-28 | Lilly Co Eli | Preparations containing lipase, protease and amylase for the treatment of pancreatic insufficiency |
| WO2006084470A2 (en) | 2005-02-10 | 2006-08-17 | Novozymes A/S | Enzymatic enantioselective ester or amide hydrolysis or synthesis |
| CA2612648A1 (en) * | 2005-06-24 | 2006-12-28 | Novozymes A/S | Lipases for pharmaceutical use |
| EP1896058A2 (en) | 2005-06-24 | 2008-03-12 | Novozymes A/S | Proteases for pharmaceutical use |
| EP1896057A2 (en) | 2005-06-24 | 2008-03-12 | Novozymes A/S | Amylases for pharmaceutical use |
| WO2007080197A2 (en) * | 2006-01-16 | 2007-07-19 | Novozymes A/S | Immobilised enzymes |
| EP2371948B1 (en) * | 2006-01-23 | 2017-04-19 | Novozymes A/S | Lipase variants |
| CA2635927A1 (en) | 2006-01-23 | 2007-08-02 | The Procter And Gamble Company | A composition comprising a lipase and a bleach catalyst |
| EP2455460A3 (en) * | 2006-12-21 | 2012-12-26 | Novozymes A/S | Lipase variants for pharmaceutical use |
-
2007
- 2007-12-12 EP EP12155315A patent/EP2455460A3/en not_active Withdrawn
- 2007-12-12 CN CN200780051638.6A patent/CN101743308B/zh active Active
- 2007-12-12 CA CA3081308A patent/CA3081308C/en active Active
- 2007-12-12 US US12/519,868 patent/US8273348B2/en active Active
- 2007-12-12 AU AU2007337150A patent/AU2007337150A1/en not_active Abandoned
- 2007-12-12 CN CN201510504893.8A patent/CN105112386A/zh active Pending
- 2007-12-12 EP EP07869130A patent/EP2099907A2/en not_active Withdrawn
- 2007-12-12 CA CA2670643A patent/CA2670643C/en active Active
- 2007-12-12 WO PCT/US2007/087168 patent/WO2008079685A2/en not_active Ceased
- 2007-12-12 EP EP10172609.9A patent/EP2261328B1/en active Active
- 2007-12-12 KR KR1020097014850A patent/KR20090101930A/ko not_active Withdrawn
- 2007-12-12 EP EP12155319.2A patent/EP2455462B1/en active Active
- 2007-12-12 EP EP12155317.6A patent/EP2455461B1/en active Active
- 2007-12-12 EP EP12155294.7A patent/EP2455459B1/en active Active
- 2007-12-12 MX MX2009006597A patent/MX2009006597A/es not_active Application Discontinuation
- 2007-12-12 BR BRPI0721103-1A patent/BRPI0721103A2/pt not_active IP Right Cessation
- 2007-12-12 RU RU2009128067/10A patent/RU2009128067A/ru not_active Application Discontinuation
- 2007-12-12 CA CA2961041A patent/CA2961041C/en active Active
- 2007-12-12 JP JP2009543078A patent/JP5406040B2/ja active Active
- 2007-12-18 TW TW096148377A patent/TW200829698A/zh unknown
- 2007-12-21 AR ARP070105859A patent/AR064494A1/es not_active Application Discontinuation
-
2009
- 2009-05-21 IL IL198893A patent/IL198893A0/en unknown
- 2009-05-25 ZA ZA200903598A patent/ZA200903598B/xx unknown
- 2009-07-20 NO NO20092729A patent/NO20092729L/no not_active Application Discontinuation
-
2012
- 2012-08-16 US US13/587,043 patent/US9029115B2/en active Active
-
2015
- 2015-04-06 US US14/679,563 patent/US9539311B2/en active Active
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2712877C2 (ru) * | 2013-05-14 | 2020-01-31 | Новозимс А/С | Моющие композиции |
| US12116601B2 (en) | 2013-05-14 | 2024-10-15 | Novozymes A/S | Detergent compositions |
| CN110462037A (zh) * | 2017-01-30 | 2019-11-15 | 学校法人日本医科大学 | 腺相关病毒(aav)衣壳蛋白的突变体 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2009128067A (ru) | Варианты липаз для их применения в фармацевтике | |
| Stafforini et al. | Mammalian platelet-activating factor acetylhydrolases | |
| Martinez et al. | Cutinase, a lipolytic enzyme with a preformed oxyanion hole | |
| Maraganore et al. | A new class of phospholipases A2 with lysine in place of aspartate 49. Functional consequences for calcium and substrate binding. | |
| Arai et al. | Platelet-activating factor acetylhydrolase (PAF-AH) | |
| Baker | Is vitellogenin an ancestor of apolipoprotein B-100 of human low-density lipoprotein and human lipoprotein lipase? | |
| Thirstrup et al. | Evidence for a pancreatic lipase subfamily with new kinetic properties | |
| Rypniewski et al. | Evolutionary divergence and conservation of trypsin | |
| Gerber-Huber et al. | Precursor-product relationship between vitellogenin and the yolk proteins as derived from the complete sequence of a Xenopus vitellogenin gene | |
| Steyaert et al. | Histidine-40 of ribonuclease T1 acts as base catalyst when the true catalytic base, glutamic acid-58, is replaced by alanine | |
| AU645583B2 (en) | Recombinantly produced lipases for therapeutical treatment | |
| CN101208429A (zh) | 用于药物用途的脂肪酶 | |
| Inaba et al. | Purification of proteasomes from salmonid fish sperm and their localization along sperm flagella | |
| JPH08508399A (ja) | ホスホリパーゼ及びヒアルロニダーゼのようなスズメバチ毒酵素のクローニング及び組換え体の生産並びにそれに基づく免疫学的治療 | |
| Teo et al. | Cloning and characterization of a novel lipase from Vibrio harveyi strain AP6 | |
| Hilton et al. | Purification and spectral study of a microbial fatty acyltransferase: activation by limited proteolysis | |
| Andryushkova et al. | Nucleotide-hydrolyzing antibodies from the sera of autoimmune-prone MRL-lpr/lpr mice | |
| Liberio et al. | The crude skin secretion of the pepper frog Leptodactylus labyrinthicus is rich in metallo and serine peptidases | |
| Guo et al. | Purification, characterization, and cDNA cloning of a myofibril-bound serine proteinase from the skeletal muscle of crucian carp (Carassius auratus) | |
| Guillemin et al. | Sequences and structural organization of phospholipase A2 genes from Vipera aspis aspis, V. aspis zinnikeri and Vipera berus berus venom: Identification of the origin of a new viper population based on ammodytin I1 heterogeneity | |
| Yamada et al. | Characterization of the platelet-activating factor acetylhydrolase from human plasma by heterologous expression in Xenopus laevis oocytes. | |
| JP7075758B2 (ja) | 活性ｐＨ範囲が広い酵素の消化促進用薬物としての使用 | |
| Lu et al. | Identification of essential residues for catalysis of rat intestinal phospholipase B/lipase | |
| Kageyama | Role of S ‘1 loop residues in the substrate specificities of pepsin A and chymosin | |
| MX2008015978A (es) | Metodo para producir lipasa, celula de yarrowia lipolytica transformada capaz de producir la lipasa y sus usos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20120110 |